Ergoteles’s Omega Healthcare OHI Stock Holding History

Ergoteles’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-91,081	Closed	-$2.69M	–	1524
2021 Q4	$2.69M	Buy	+91,081	New	+$2.66M	0.1%	207
2020 Q4	–	Sell	-14,600	Closed	-$437K	–	844
2020 Q3	$437K	Buy	+14,600	New	+$456K	0.06%	261

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ergoteles's OHI Position: Q1 2022 in Review

Ergoteles sold out of Omega Healthcare (OHI) in Q1 2022, closing a stake of 91,081 shares — an estimated $2.69M sold.

Ergoteles first reported a position in OHI in Q3 2020 and held it in 2 quarters. The position peaked at $2.69M in Q4 2021. 488 funds tracked by Wall St. Rank hold OHI as of Q1 2022.

Ergoteles reported no remaining Omega Healthcare position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 91,081 Omega Healthcare shares in Q1 2022, an estimated $2.69M.
Ergoteles first reported a position in Omega Healthcare in Q3 2020 and held it in 2 quarters.
Ergoteles's Omega Healthcare position peaked at $2.69M in Q4 2021.
488 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.